CHI3L1 and in situ carcinoma: In 2016, another investigation further strengthened these previous data: Borras and colleagues were able to build a statistical model for conversion from CIS to RRMS based on the CSF levels of CHI3L1 and ala-β-his-dipeptidase [170].